tributyrin has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beland, FA; Campos, A; Carrilho, J; de Conti, A; Furtado, KS; Fuscoe, JC; Guariento, AH; Han, T; Moreno, FS; Pogribny, IP; Purgatto, E; Ross, SA; Shinohara, EM; Tryndyak, V | 1 |
| Basak, G; Czajka, A; Giermasz, A; Hoser, G; Jakóbisiak, M; Jalili, A; Lewandowski, S; Makowski, M; Marczak, M; Młynarczuk, I; Nowis, D; Stok osa, T | 1 |
2 other study(ies) available for tributyrin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.
Topics: Animals; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Folic Acid; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Humans; Liver Neoplasms; Male; Neoplasm Proteins; Neovascularization, Pathologic; Rats; Transcriptome; Triglycerides | 2014 |
Antitumor activity of tributyrin in murine melanoma model.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Butyric Acid; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Prodrugs; Time Factors; Triglycerides; Tumor Cells, Cultured | 2001 |